Liquidia Corporation · 1 day ago
Director, Clinical Program Management
Liquidia Corporation is dedicated to the discovery and development of innovative therapies for patients with pulmonary hypertension. The Director of Clinical Program Management will provide strategic leadership and coordinate with various functional leads to deliver key assets, focusing on bringing transformative therapies to market.
Responsibilities
Develop and implement cross-functional development plans at both a strategic and tactical level. Understand functional interfaces and drive cross-functional alignment to achieve corporate milestones
Escalate risk effectively to senior management, while also developing and implementing mitigation strategies
Ability to consistently think of the bigger picture, so that commercial viability of development programs is adequately assessed throughout the product life cycle
Facilitate regular team and cross-functional meetings, develop dashboards, and provide status updates to senior management
Assist with the budgeting process, tracking study and operational budgets to ensure efficient allocation of resources across projects
Monitor evolving regulatory requirements as well as key milestones of competitors to ensure proactive planning
Qualification
Required
Bachelor's degree and a minimum of 12 years of relevant experience with a focus on matrix management
Experience with program management from IND to NDA/BLA and global launch including a solid understanding of global registration processes
Experience in biotech/pharmaceutical industry with a demonstrated understanding of cross-functional interdependencies (i.e., R&D, commercial, technical development, regulatory)
Demonstrated ability to lead, motivate, influence without authority a strategic direction; ability to effectively leverage and develop diverse perspectives and ideas from matrix teams and others
Excellent communication, negotiation, problem solving and decision-making abilities
Demonstrated ability to identify critical program risks and develop mitigation plans – strategic or tactical to mitigate risk, and costs
Demonstrated technical experience and success supporting clinical-to-commercial transitions in small molecule and inhaled combination products
Proven experience managing complexity in global programs across multiple modalities
Preferred
Advanced degree (MS, PhD, MBA) preferred in a relevant biopharmaceutical discipline
Experience with Phase 4 studies is also preferred
Experience supporting combination device programs, inhaled technologies and/or small molecules is strongly preferred
Experience with PAH, IPF, or other rare diseases is highly preferred
Benefits
Medical
Dental
Vision
STD
LTD
401(k) Savings Retirement Plan
ESPP
Unlimited Paid Time Off
Company
Liquidia Corporation
Liquidia Corporation is a biopharmaceutical company focused on the development and commercialization of products in pulmonary hypertension and other applications of its PRINT® Technology.
Funding
Current Stage
Public CompanyTotal Funding
$533.4MKey Investors
HealthCare Royalty PartnersPatient Square CapitalSilicon Valley Bank
2025-06-23Post Ipo Debt· $50M
2024-09-11Post Ipo Equity· $67.5M
2024-01-04Post Ipo Equity· $75M
Leadership Team
Recent News
2026-01-07
New Enterprise Associates
2026-01-06
Company data provided by crunchbase